share_log

ANGELALIGN: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2024

HKEX ·  Mar 20 19:33

Summary by Futu AI

時代天使2024年度收入同比增長28.2%至2.69億美元,淨利潤增長46.6%至1000萬美元,毛利率保持在62.6%。隱形矯治達成案例總數增長46.7%至359,400例,其中中國以外全球市場案例數增長326.4%至140,700例,佔比達39.1%。中國以外全球市場收入大幅增長290.4%至8050萬美元,佔總收入30%。公司持續推進「數字化和全球化」雙引擎發展戰略,業務已遍佈50多個國家。在產品創新方面,推出智能化算法「新版A6?板」,大幅升級「經典版」產品,並在早期矯治領域推出「KiD Max」和「KiD防齲版」子產品線。研發投入達2130萬美元,佔總收入7.9%。展望未來,公司將繼續加強研發能力、革新隱形正畸解決方案、提升數字化系統、擴大銷售網絡,並進一步開拓全球市場。董事會建議派發特別末期股息每股0.38港元。同時需關注全球經濟復甦不確定性、地緣政治衝突等外部風險因素對業務的潛在影響。
時代天使2024年度收入同比增長28.2%至2.69億美元,淨利潤增長46.6%至1000萬美元,毛利率保持在62.6%。隱形矯治達成案例總數增長46.7%至359,400例,其中中國以外全球市場案例數增長326.4%至140,700例,佔比達39.1%。中國以外全球市場收入大幅增長290.4%至8050萬美元,佔總收入30%。公司持續推進「數字化和全球化」雙引擎發展戰略,業務已遍佈50多個國家。在產品創新方面,推出智能化算法「新版A6?板」,大幅升級「經典版」產品,並在早期矯治領域推出「KiD Max」和「KiD防齲版」子產品線。研發投入達2130萬美元,佔總收入7.9%。展望未來,公司將繼續加強研發能力、革新隱形正畸解決方案、提升數字化系統、擴大銷售網絡,並進一步開拓全球市場。董事會建議派發特別末期股息每股0.38港元。同時需關注全球經濟復甦不確定性、地緣政治衝突等外部風險因素對業務的潛在影響。
AngelAlign's revenue for the fiscal year 2024 increased by 28.2% year-on-year to $0.269 billion, with net profit growing by 46.6% to $10 million, and the gross margin remained at 62.6%. The total number of cases for invisible correction increased by 46.7% to 359,400, with cases outside of China growing by 326.4% to 140,700, accounting for 39.1%. Revenue from the global market outside of China surged by 290.4% to $80.5 million, accounting for 30% of total revenue. The company continues to advance its "digitalization and globalization" dual-engine development strategy, with its Business extending across over 50 countries. In terms of product innovation, the intelligent algorithm "New Version A6 board" was launched, significantly upgrading the "Classic Version" product, and introducing sub-product lines "KiD Max" and "KiD Anti-Caries Version" in the early intervention...Show More
AngelAlign's revenue for the fiscal year 2024 increased by 28.2% year-on-year to $0.269 billion, with net profit growing by 46.6% to $10 million, and the gross margin remained at 62.6%. The total number of cases for invisible correction increased by 46.7% to 359,400, with cases outside of China growing by 326.4% to 140,700, accounting for 39.1%. Revenue from the global market outside of China surged by 290.4% to $80.5 million, accounting for 30% of total revenue. The company continues to advance its "digitalization and globalization" dual-engine development strategy, with its Business extending across over 50 countries. In terms of product innovation, the intelligent algorithm "New Version A6 board" was launched, significantly upgrading the "Classic Version" product, and introducing sub-product lines "KiD Max" and "KiD Anti-Caries Version" in the early intervention sector. R&D investment reached $21.3 million, accounting for 7.9% of total revenue. Looking ahead, the company will continue to enhance R&D capabilities, innovate invisible orthodontic solutions, improve digital systems, expand the sales network, and further explore the Global market. The Board of Directors recommends the distribution of a special final dividend of HK$0.38 per share. Attention must also be paid to external risk factors such as uncertainties in the recovery of the global economy and geopolitical conflicts that may potentially impact the Business.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.